Total Payments
$16,965
2024 Payments
$4,963
Companies
33
Transactions
810
Medicare Patients
3,348
Medicare Billing
$279,017
Payment Breakdown by Category
Food & Beverage$16,855 (99.4%)
Education$109.99 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,855 | 808 | 99.4% |
| Education | $109.99 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,334 | 82 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,456 | 127 | $0 (2024) |
| Galderma Laboratories, L.P. | $1,444 | 62 | $0 (2024) |
| Janssen Biotech, Inc. | $1,277 | 52 | $0 (2024) |
| REVANCE THERAPEUTICS, INC. | $1,223 | 20 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,009 | 38 | $0 (2024) |
| Lilly USA, LLC | $954.10 | 43 | $0 (2024) |
| GENZYME CORPORATION | $805.33 | 32 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $763.23 | 55 | $0 (2024) |
| MAYNE PHARMA INC. | $561.45 | 72 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,963 | 191 | REVANCE THERAPEUTICS, INC. ($1,223) |
| 2023 | $2,779 | 160 | Janssen Biotech, Inc. ($349.25) |
| 2022 | $2,837 | 151 | Novartis Pharmaceuticals Corporation ($459.47) |
| 2021 | $2,041 | 90 | Galderma Laboratories, L.P. ($334.79) |
| 2020 | $1,138 | 47 | MERZ NORTH AMERICA, INC. ($192.49) |
| 2019 | $1,686 | 132 | Mayne Pharma Inc. ($426.05) |
| 2018 | $1,520 | 39 | AbbVie, Inc. ($664.00) |
All Payment Transactions
810 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Immunology | ||||||
| 12/20/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $18.88 | General |
| 12/13/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $114.69 | General |
| 12/13/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: DERMATOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $28.50 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $10.34 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $76.64 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/20/2024 | Almirall LLC | Seysara (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.45 | General |
| 11/18/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.39 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $3.80 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Solta Medical, a division of Bausch Health US, LLC | CLEAR+BRILLIANT | Food and Beverage | In-kind items and services | $149.48 | General |
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/12/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Immunology | ||||||
| 11/09/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Dermatology | ||||||
| 11/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.33 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 750 | 1,445 | $184,810 | $58,211 |
| 2022 | 13 | 790 | 1,616 | $218,122 | $70,277 |
| 2021 | 12 | 903 | 1,788 | $240,630 | $81,599 |
| 2020 | 12 | 905 | 1,630 | $208,858 | $68,930 |
Total Patients
3,348
Total Services
6,479
Medicare Billing
$279,017
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 129 | $33,901 | $10,855 | 32.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 133 | 171 | $31,770 | $9,926 | 31.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 79 | 98 | $20,635 | $6,285 | 30.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 123 | 163 | $22,650 | $5,878 | 26.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 56 | 65 | $15,281 | $5,080 | 33.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 21 | 28 | $9,830 | $3,340 | 34.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $10,951 | $3,253 | 29.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 53 | 53 | $12,237 | $3,208 | 26.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 96 | 610 | $8,391 | $3,189 | 38.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 11 | 12 | $7,591 | $2,976 | 39.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 30 | 57 | $5,951 | $2,305 | 38.7% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 13 | 13 | $3,989 | $1,322 | 33.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 14 | $1,632 | $594.10 | 36.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 95 | 149 | $39,694 | $13,584 | 34.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 135 | 194 | $36,631 | $11,703 | 31.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 77 | 102 | $24,423 | $8,057 | 33.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 95 | 124 | $26,876 | $7,936 | 29.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 130 | 198 | $27,962 | $7,045 | 25.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 20 | 34 | $12,081 | $4,561 | 37.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 99 | 637 | $9,084 | $3,476 | 38.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 29 | 29 | $10,074 | $3,039 | 30.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 12 | 12 | $7,695 | $2,982 | 38.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 40 | 40 | $9,325 | $2,800 | 30.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 28 | 64 | $6,911 | $2,705 | 39.1% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2022 | 15 | 18 | $5,602 | $1,800 | 32.1% |
About Danielle Applebaum
Danielle Applebaum is a Dermatology healthcare provider based in Katy, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2014. The National Provider Identifier (NPI) number assigned to this provider is 1073931812.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Danielle Applebaum has received a total of $16,965 in payments from pharmaceutical and medical device companies, with $4,963 received in 2024. These payments were reported across 810 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($16,855).
As a Medicare-enrolled provider, Applebaum has provided services to 3,348 Medicare beneficiaries, totaling 6,479 services with total Medicare billing of $279,017. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Katy, TX
- Active Since 03/30/2014
- Last Updated 09/18/2018
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1073931812
Products in Payments
- DUPIXENT (Biological) $1,519
- TREMFYA (Drug) $1,226
- DAXXIFY (Drug) $1,223
- COSENTYX (Biological) $833.40
- TALTZ (Drug) $757.87
- Humira (Biological) $676.11
- SKYRIZI (Biological) $610.84
- COSENTYX (Drug) $571.39
- DORYX (Drug) $561.45
- Otezla (Drug) $496.94
- Winlevi (Drug) $481.59
- OPZELURA (Drug) $436.62
- Sotyktu (Drug) $400.96
- VTAMA (Drug) $381.42
- EUCRISA (Drug) $307.65
- Zoryve (Drug) $285.41
- RINVOQ (Biological) $259.59
- HUMIRA (Biological) $256.05
- Impoyz (Drug) $239.05
- Tolak (Drug) $204.16
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Katy
Connie Wang, M.d, M.D
Dermatology — Payments: $55,293
Dermatology $55,293
Filiberto Cedeno Laurent, Md, Phd, MD, PHD
Dermatology — Payments: $23,083
Dermatology $23,083
Uyen Ngoc Mui, Md, MD
Dermatology — Payments: $10,381
Dermatology $10,381
Rachel Schmidtberger, M.d, M.D
Dermatology — Payments: $9,055
Dermatology $9,055
Dr. Sana Zahiruddin, M.d, M.D
Dermatology — Payments: $8,857
Dermatology $8,857
Lindsey Denny, M.d, M.D
Dermatology — Payments: $8,345
Dermatology $8,345